ALNY vs TREX · P/E 76, rev $1.29B vs P/E 25, rev $761.4M
Alnylam Pharmaceuticals Inc (ALNY) versus Trex Company Inc (TREX) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Trex Company Inc (TREX) is a building products & equipment company listed on NYSE.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported TREX revenue for 2026-06-30 was $761.4M. Net income was $123.3M. TREX currently screens at market cap $4.72B and trailing P/E 25.3.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. TREX currently screens at market cap $4.72B and trailing P/E 25.3.
Not investment advice. Open the ALNY and TREX stock pages for the full models.
Not investment advice.